NEW YORK STATE TEACHERS RETIREMENT SYSTEM - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 213 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
NEW YORK STATE TEACHERS RETIREMENT SYSTEM ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$992
-2.4%
34,683
-0.3%
0.00%0.0%
Q1 2024$1,016
-13.5%
34,7830.0%0.00%
-33.3%
Q4 2023$1,174
+10.0%
34,7830.0%0.00%0.0%
Q3 2023$1,067
-24.1%
34,783
-0.9%
0.00%0.0%
Q2 2023$1,406
-3.2%
35,083
-1.4%
0.00%0.0%
Q1 2023$1,452
+4.9%
35,583
-0.7%
0.00%0.0%
Q4 2022$1,384
-99.9%
35,836
+0.3%
0.00%
-40.0%
Q3 2022$1,901,000
-8.5%
35,736
+0.3%
0.01%0.0%
Q2 2022$2,078,000
-23.4%
35,636
+0.3%
0.01%
-16.7%
Q1 2022$2,712,000
+26.8%
35,5360.0%0.01%
+50.0%
Q4 2021$2,138,000
+7.4%
35,5360.0%0.00%0.0%
Q3 2021$1,990,000
-8.2%
35,536
-0.5%
0.00%
-20.0%
Q2 2021$2,167,000
-13.4%
35,7090.0%0.01%0.0%
Q1 2021$2,503,000
+19.5%
35,709
+2.0%
0.01%0.0%
Q4 2020$2,095,000
-0.5%
35,0110.0%0.01%0.0%
Q3 2020$2,105,000
+11.4%
35,011
-2.8%
0.01%0.0%
Q2 2020$1,890,000
+57.0%
36,012
+0.3%
0.01%
+25.0%
Q1 2020$1,204,000
-17.8%
35,912
+11.1%
0.00%
+33.3%
Q4 2019$1,464,000
+133.5%
32,312
+96.1%
0.00%
+50.0%
Q3 2019$627,00016,4750.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Tamarack Advisers, LP 273,000$8,818,0006.24%
Standard Investments LLC 775,388$25,045,0004.58%
ARMISTICE CAPITAL, LLC 400,000$12,920,0003.06%
HealthCor Management, L.P. 1,575,000$50,873,0002.88%
DARUMA CAPITAL MANAGEMENT LLC 1,219,642$39,394,0002.24%
Consonance Capital Management LP 631,805$20,407,0002.24%
Rock Springs Capital Management LP 713,000$23,030,0001.54%
Biondo Investment Advisors, LLC 142,473$4,602,0001.52%
Opus Point Partners Management, LLC 50,000$1,615,0001.29%
Partner Investment Management, L.P. 26,690$862,0001.14%
View complete list of PACIRA PHARMACEUTICALS INC shareholders